Jose Olague

Carterra, Inc. engages in provision of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. It offers Kinetics software, Epitope mapping, therapeutic areas, and antibody formats. The company was founded by James Smith and Josh Eckman in 2005 and is headquartered in Salt Lake City, UT.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Antech Diagnostics, Inc. provides veterinary laboratory network services. It offers CellaVision and digital pathology, and peer-to-peer case support. The company is headquartered in Los Angeles, CA.

Integrated DNA Technologies, Inc. manufactures nucleic acid products. It specializes in DNA synthesis, gene construction, antisense oligos, molecular beacons, and a variety of molecular biology products. The company was founded by Joseph A. Walder in 1987 and is headquartered in Skokie, IL.

Dynex Technologies, Inc. develops laboratory and clinical instruments. It focuses on research of microplate analysis. The firm products include, DSX four-plate system, SpectraMR scanning spectrophotometer, MLX luminometer, UltraWash Plus washer, MRW multi-buffer washer and Fluorolux HB microplate. The company was founded in 1952 and is headquartered in Chantilly, VA

Clifford Chance LLP provides legal services. It services include banking and finance, capital markets, mergers and acquisitions, litigation and dispute resolution, real estate and tax, pensions and employment. The company was founded in 1987 and is headquartered in London, the United Kingdom.

The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME.

Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA.

PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands.

Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden.

Telegraph Hill Partners Management Co. LLC (Telegraph Hill Partners) is a venture capital firm founded in 2001 by Robert G. Shepler, Thomas A. Raffin and Deval A. Lashkari. The firm is headquartered in San Francisco, California.

MediService AG is a mail service pharmacy. The company is headquartered in Zuchwil, Switzerland.

Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Blue Mountain Capital Group LLC (Private Equity) (Blue Mountain Capital) is a private equity subsidiary of Assured Investment Management LLC founded in 2012 by Andrew Todd Feldstein. The firm is headquartered in New York.

Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA.

Argonaut Manufacturing Services, Inc. engages in providing contract manufacturing in the life science and biotech arena. It offers products launch, scale-up & volume, decline and sunset services. The company was founded in 2016 and is headquartered in Carlsbad, CA.

Cell Microsystems, Inc. develops, manufactures and commercializes products and tools for the isolation, recovery and analysis of single cells. The company was founded by Yuli Wang, Nancy Allbritton and Christopher Sims in 2002 and is headquartered in Durham, NC.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.

Part of Varex Imaging Corp., Varex Imaging Deutschland AG is a German company that manufactures and supplies X-ray tubes and image processing solutions. The company is based in Willich, Germany.

Excellos, Inc. is a full-service contract development and manufacturing organization (CDMO) based in San Diego, CA. Excellos is focused on supplying cGMP cellular products and services, as well as process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. The company is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies. Excellos accelerates cell and gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services. The company's proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. The company was founded in 2020 and is led by CEO David Wellis.

VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation.